Beacon Pointe Advisors, LLC Bionomics Limited Transaction History
Beacon Pointe Advisors, LLC
- $8.35 Billion
- Q2 2024
A detailed history of Beacon Pointe Advisors, LLC transactions in Bionomics Limited stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 10,000 shares of BNOX stock, worth $5,300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$5,300
Previous $10,000
30.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BNOX
# of Institutions
12Shares Held
1.64MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY1.23MShares$650,1820.01% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct316KShares$167,4800.0% of portfolio
-
Ubs Group Ag34.9KShares$18,4950.0% of portfolio
-
Two Sigma Securities, LLC New York, NY26KShares$13,8000.0% of portfolio
-
Two Sigma Investments, LP New York, NY16.4KShares$8,6760.0% of portfolio
About BIONOMICS LIMITED
- Ticker BNOX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,518,620
- Market Cap $3.98M
- Description
- Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has ...